PADAGIS
LIVE

Serial Number

97260096

Owner

Padagis LLC

Attorney

Andrea M. Porterfield

Filing Date

Feb 9, 2022

Add to watchlist:

No watchlists yet
View on USPTO

PADAGIS Trademark

Serial Number: 97260096 • Registration: 6944923

PADAGIS is a trademark filed by Padagis LLC on February 9, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Padagis LLC (3 trademarks)

10 E. 53rd St., 31st Fl.
New York, NY 10022

Entity Type: 16

Trademark Details

Filing Date

February 9, 2022

Registration Date

January 3, 2023

Published for Opposition

August 2, 2022

Goods & Services

Custom manufacture of pharmaceutical preparations for others

Pharmaceutical preparations for the treatment of dermatological, ophthalmic, respiratory, bacterial-based, urological, hormonal, gastrointestinal, cardiovascular, and psychiatric diseases and disorders; pharmaceutical preparations for the treatment of diabetes, migraines, and seizures; pharmaceutical preparations for use in pain management; transdermal patches for use in the treatment of nausea, vomiting; transdermal patches for the delivery of hormonal preparations; pharmaceutical preparations for inhalation for use in treatment of respiratory diseases and disorders and COPD; inhalers sold filled with aerosol inhalation preparations for the treatment of respiratory and neurological diseases and disorders; nasal and oral spray preparations for the treatment of bacterial-based, cardiovascular, hormonal, migraines, seizures, pain management, respiratory, neurological, and dermatological diseases and disorders; anti-infective preparations; antiviral preparations; antibiotics; antifungal preparations; anti-inflammatory preparations; cough treatment preparations; pharmaceutical preparations for use as a vehicle for compounding other pharmaceuticals

Research and development in the fields of pharmaceuticals and medicine; research and development of new products for others; research and development of pharmaceutical preparations; design of pharmaceutical preparations; testing of pharmaceutical preparations

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 3, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 3, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 30, 2022 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 29, 2022 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Nov 16, 2022 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 9, 2022 AITU
USE AMENDMENT FILED
Oct 25, 2022 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 25, 2022 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 27, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 2, 2022 NPUB
PUBLISHED FOR OPPOSITION
Aug 2, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 13, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 27, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 23, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 23, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 23, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 24, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 24, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 24, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 12, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 16, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 15, 2022 NWOS
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 14, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 14, 2022 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 14, 2022 COAR
NEW APPLICATION ENTERED
Feb 12, 2022 NWAP